| Company/Division name | Cue Health, Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | In-house |
| City reshored to: | San Diego |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | cartridge-based point-of-care molecular test kits |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Image/brand, Impact on domestic economy, Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training, Under-utilized capacity, Other, Covid-19 |
| Government Incentive dollar amount: | $481 million |
